Latest DuchenneMuscularDystrophy News and Updates : DuchenneMuscularDystrophy updates, DuchenneMuscularDystrophy News , DuchenneMuscularDystrophy around the world

Nishadil

Washington | 20°C (light rain)

A Remarkable Leap: Lab-Grown Canine Muscle Cells Transform Duchenne Muscular Dystrophy Research

Top story

A Remarkable Leap: Lab-Grown Canine Muscle Cells Transform Duchenne Muscular Dystrophy Research

In focus

Latest feed

Regenxbio's Gene Therapy Journey Hits a Couple of Bumps in the Road

REGENXBIO's Rollercoaster Ride: A Tale of Two Gene Therapies

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning

Latest headlines

The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor

The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor

A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge

A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge

A Beacon of Hope and a Stock Market Phenomenon: The Capricor Therapeutics Story

A Beacon of Hope and a Stock Market Phenomenon: The Capricor Therapeutics Story

A Beacon of Hope: Capricor's Cell Therapy Shows Remarkable Heart Improvements in Duchenne Patients

A Beacon of Hope: Capricor's Cell Therapy Shows Remarkable Heart Improvements in Duchenne Patients

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

The High Stakes Game: Sarepta, Duchenne, and the Edge of Hope

The High Stakes Game: Sarepta, Duchenne, and the Edge of Hope

The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic

The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic

The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs

The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs

A Beacon of Hope: Gene Therapy Milestone Honors Jesse Den Haan's Legacy in the Fight Against Duchenne Muscular Dystrophy

A Beacon of Hope: Gene Therapy Milestone Honors Jesse Den Haan's Legacy in the Fight Against Duchenne Muscular Dystrophy

Solid Biosciences Forges Strategic Alliance with Kinea Bio for Friedreich's Ataxia Gene Therapy, Bolstering Focus on DMD Pipeline

Solid Biosciences Forges Strategic Alliance with Kinea Bio for Friedreich's Ataxia Gene Therapy, Bolstering Focus on DMD Pipeline

A New Horizon for Duchenne: FDA Approves First Gene Therapy for Life-Threatening Disease in Boys

A New Horizon for Duchenne: FDA Approves First Gene Therapy for Life-Threatening Disease in Boys

Dallas Scientist's CRISPR Breakthrough Ignites Hope for Muscular Dystrophy, Eyes on Nobel Prize Amidst Ethical Complexities

Dallas Scientist's CRISPR Breakthrough Ignites Hope for Muscular Dystrophy, Eyes on Nobel Prize Amidst Ethical Complexities

Load more